Alopecia: The Questions We Need to Answer

    February 2018 in “ British Journal of Dermatology ”
    Susan Holmes
    Image of study
    TLDR We need better research to improve alopecia treatment and patient care.
    In the document from February 1, 2018, the authors discuss the challenges and uncertainties in the management, prevention, diagnosis, and treatment of alopecia. They highlight that hair loss is common, with an estimated 50% of men and 40% of women experiencing patterned hair loss by the age of 50 and 70, respectively. The psychological impact of alopecia is significant, yet the quality of evidence for many treatments is poor, often based on anecdotal evidence rather than randomized controlled trials. To address these issues, the British Hair and Nail Society initiated a Hair Loss Priority Setting Partnership (PSP) with the James Lind Alliance to identify research priorities in alopecia management. An initial survey gathered 2747 uncertainties from 912 respondents, which were refined to 56 questions and then to a top 10 list through a consensus process. The document emphasizes the need to present these research priorities to funding bodies to initiate high-quality studies and improve patient outcomes.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results
      Alopecia: Children Are Not Just Little People

      research Alopecia: Children Are Not Just Little People

      8 citations, September 2015 in “Clinics in Dermatology”
      Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.
      Sudden Onset Hair Loss and Color Change

      research Sudden Onset Hair Loss and Color Change

      1 citations, October 2013 in “BMJ”
      A man's sudden hair loss and color change to white was diagnosed as alopecia areata and it improved on its own after six months.